Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters

Document Type
Year range
1.
2.
European Psychiatry ; 65(Supplement 1):S584, 2022.
Article in English | EMBASE | ID: covidwho-2154129

ABSTRACT

Introduction: Concerns about health and fitness during lockdown may serve as a trigger for eating disorders in vulnerable individuals. Other risk factors may also include increased use of social networks and comparison with beauty ideals. Isolation, loneliness and problems with emotional regulation may lead people to reduce food intake by giving them a greater sense of control. Objective(s): Emphasise the relevance of the increase in the incidence of Eating Disorders (ED) cases during the pandemic. Method(s): Review of the scientific literature based on a relevant clinical case. Result(s): 14-year-old female, residing with her mother. She reports that from the beginning of COVID-19 confinement she became obsessed with leading a healthier life, starting to restrict food, limiting fats and carbohydrates, and having also started compulsive physical activity (approximately 4 hours of aerobic exercise per day), without associated purging behaviours. She also acknowledges eating small amounts (although she minimises this aspect) and controlling all calories, stating that food and practices aimed at "staying healthy" now dominate her life. Her previous BMI was 18, with a current BMI of 11.7. Conclusion(s): Patients suffering from ED, who often have poor knowledge of their illness and find social-emotional communication difficult, may delay seeking help. Studies suggest the relevance of identifying specific vulnerability factors among ED patients in confinement in order to develop preventive strategies and personalised treatment approaches.

3.
European Psychiatry ; 65(Supplement 1):S436, 2022.
Article in English | EMBASE | ID: covidwho-2153947

ABSTRACT

Introduction: The Covid-19 pandemic has had a significant impact on the mental health of adolescents. Several descriptive studies and systematic reviews have shown an increase in suicide rates in this age group. Objective(s): - To present a literary review on the impact of the Covid-19 pandemic on the mental health and suicidal behavior of adolescents around the world. - To present data on admission rates due to suicidal behavior during the first year of the Covid-19 pandemic in a Spanish child-adolescent psychiatric hospitalization unit. Method(s): - We will present a literature review and a retrospective cross-sectional study on admission rates for suicidal behavior in a child-adolescent psychiatric hospitalization unit. - Admission rates for suicidal behavior during the year prior to the pandemic will be compared with rates relative to the first year of the pandemic. Result(s): - We have found a significant increase in admission rates for suicidal behavior during the year of the pandemic. Similar results have been found in different studies and meta-analyzes. - The socio-demographic characteristics of the patients are quite similar in the two periods of time analyzed, but the reference to intra-family problems has been more frequent in the year of the pandemic. Conclusion(s): Our data is in line with other studies suggesting that the Covid-19 pandemic has had a strong impact on teenage suicidal behavior.

4.
Annals of Oncology ; 31:S1010, 2020.
Article in English | EMBASE | ID: covidwho-803939

ABSTRACT

Background: Patients with cancer are more susceptible to infection because of immunosuppressive treatment given to cure cancer. Several guidelines published at the beginning of the COVID-19 pandemic recommend delaying systemic anticancer treatment until complete resolution of COVID-19 symptoms. In addition, it is important to segregate patients with cancer from patients with COVID-19 to avoid transmission. Nevertheless, some patients will present both diseases, and the duration of eviction from cancer units and delay of cancer treatment after COVID-19 remains unclear. Notably the duration of viral excretion after COVID-19 is a concern in immunosuppressed patients. Methods: We tested all patients with a confirmed initial diagnosis of COVID-19 who needed to receive cancer or immunosuppressive treatment for a solid tumour, haematological or inflammatory disease in our centre from April 1st to May 15th 2020. We have repeated SARS-COV2 RT-PCR until negative viral shedding. Results: We tested 49 consecutive patients: 53% had solid tumours, 37% haematological disease and 10% inflammatory disease. 59% were under 65 years. Overall, 82% of patients had a positive RT-PCR from day 14 to 20 after the initial diagnosis of COVID-19 infection, 60% from day 21 to 27 and 30% from day 28 to 34. Only 4/37 patients evaluated remained with a positive RT-PCR after day 35. No predictive factors were associated with a positive RT-PCR but our results suggest that patients treated for inflammatory disease had a shorter duration of positive RT-PCR. 18 patients had their treatment delayed according to guideline recommendations and 17 patients received their treatment in a dedicated COVID-19 outpatient unit. No symptomatic COVID-19 recurrence was observed during follow-up in patients who had received chemotherapy despite persistent positive RT-PCR. Conclusions: We report here the first assessment of SARS-CoV2 RT-PCR kinetic in cancer patients. A prolonged viral excretion is observed in patients treated for cancer. A systematic retest is needed after day 14 if RT-PCR remains positive. A specific unit dedicated to outpatients with persistent positive RT-PCR allows urgent anticancer treatment and avoids the risk of viral exposure for other immunodepressed patients. Legal entity responsible for the study: The authors. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.

5.
Hepato-Gastro et Oncologie Digestive ; 27(5):486-489, 2020.
Article in French | EMBASE | ID: covidwho-686816

ABSTRACT

To date, there are no studies on COVID-19 specifically dedicated to patients with gastrointestinal cancer. Current data based on small Chinese studies suggest that SARS-CoV-2 infection is 2 to 3 times more common in cancer patients than in the general population and associated with more serious and lethal forms of COVID-19. However, these data need to be confirmed and completed. A French cohort of Cooperative Groups in Oncology, dedicated to cancer patients and COVID-19 (GCO-02 CACOVID-19) and promoted by the FFCD, is currently open to inclusions in an attempt to improve knowledge in this area. While waiting to learn more, the epidemic has led groups of experts and societies to propose recommendations aimed at protecting cancer patients from contamination, limiting situations at risk and organizing in the best conditions the continuation of anti-cancer treatments. In this context, a new chapter of the National Thesaurus of Digestive Oncology dedicated to the management of digestive cancers according to the COVID-19 epidemic situation has been posted on the SNFGE website and is regularly updated.

SELECTION OF CITATIONS
SEARCH DETAIL